I

f President Trump has his way, Dr. Scott Gottlieb will be the next FDA commissioner. Here’s what we know about his views — and what they might mean for the agency’s future.

He wants to change how the FDA reviews drugs

Gottlieb hasn’t advocated radical, baby-with-bathwater reforms, but he has proposed a tweak that would shake things up.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for Morning Rounds

A daily dose of health and medicine news — and a finalist for Digiday’s best email newsletter.

Recommended Stories